Jade Biosciences, Inc.
Clinical trials sponsored by Jade Biosciences, Inc., explained in plain language.
-
New RA drug JADE201 enters first human safety trial
Disease control Recruiting nowThis early-stage trial tests a single injection of JADE201 in 36 adults with rheumatoid arthritis. The main goal is to check safety and how the body processes the drug. Participants receive either JADE201 or a placebo, and researchers monitor side effects and drug levels in the b…
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for kidney disease: JADE101 trial launches
Disease control Recruiting nowThis study tests a new drug, JADE101, in 30 adults with IgA nephropathy, a kidney disease. The goal is to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Participants must be on stable standard care and have a kidney biopsy confirming the dis…
Phase: PHASE2 • Sponsor: Jade Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug JADE101 tested in healthy volunteers for first time
Knowledge-focused Recruiting nowThis Phase 1 trial is testing a single dose of JADE101 in 40 healthy Japanese and Chinese adults to see if it is safe and how the body processes it. Researchers will monitor side effects and measure drug levels in the blood. This is an early step to gather basic safety informatio…
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC